Methylgene ULC
Records under this name other than patents Methylgene ULC holds now: patents now held by others, patents whose terms have ended, and its applications, pending or abandoned.
Showing 1 to 8 of 8 · Back to Methylgene ULC
| Patent | Title | Status | Expires | Confidence |
|---|---|---|---|---|
| US 8,389,541 | Inhibitors of Protein Tyrosine Kinase Activity Formerly held In force · High confidence | In force | High confidence | |
| US 8,569,503 | Processes and Intermediates for Preparing Fused Heterocyclic Kinase Inhibitors Formerly held In force · High confidence | In force | High confidence | |
| US 8,846,927 | Inhibitors of Protein Tyrosine Kinase Activity Formerly held In force · Medium confidence | In force | Medium confidence | |
| US 9,018,378 | Processes and Intermediates for Preparing Fused Heterocyclic Kinase Inhibitors Formerly held In force · Medium confidence | In force | Medium confidence | |
| US 8,404,846 | Inhibitors of Protein Tyrosine Kinase Activity Formerly held In force · Medium confidence | In force | Medium confidence | |
| US 8,093,264 | Fused Heterocycles as Inhibitors of VEGF Receptor and HGF Receptor Signaling Formerly held In force · High confidence | In force | High confidence | |
| US 8,907,091 | Processes and Intermediates for Preparing Fused Heterocyclic Kinase Inhibitors Formerly held In force · High confidence | In force | High confidence | |
| US 8,329,726 | Inhibitors of VEGF Receptor and HGF Receptor Signaling Formerly held Term ended Term ended May 19, 2026 · High confidence | Term ended | Term ended May 19, 2026 | High confidence |